DAN plays important compensatory roles in systemic‐to‐pulmonary shunt associated pulmonary arterial hypertension-Reference-Cited by-同舟云学术

DAN plays important compensatory roles in systemic‐to‐pulmonary shunt associated pulmonary arterial hypertension

Published:2019-02-27 Issue:3 Volume:226 Page:e13263
ISSN:1748-1708
Container-title:Acta Physiologica
language:en
Short-container-title:Acta Physiol

Author:

Meng Liukun¹,Liu Xiaoyan²³,Teng Xiao¹,Yuan Wen²³,Duan Lihua⁴,Meng Jian¹,Li Jun¹,Zheng Zhe¹,Wei Yingjie¹,Hu Shengshou¹^ORCID

Affiliation:

1. State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College Chinese Academy of Medical Sciences Beijing China

2. Medical Research Center, Beijing Chao‐Yang Hospital Capital Medical University Beijing China

3. Heart Center & Beijing Key Laboratory of Hypertension Research, Beijing Chaoyang Hospital Capital Medical University Beijing China

4. Department of Rheumatology and Clinical Immunology Jiangxi Provincial People's Hospital Nanchang China

Funder

Natural Science Foundation of Beijing Municipality

Publisher

Wiley

Subject

Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apha.13263

Reference36 articles.

1. Updated Clinical Classification of Pulmonary Hypertension

2. BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension

3. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

4. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH

5. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA NIPA1-SO confers atherosclerotic protection by suppressing the transmembrane protein NIPA1;Journal of Advanced Research;2023-12

2. Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease;American Journal of Respiratory Cell and Molecular Biology;2022-12

3. Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension;International Journal of Biological Sciences;2022

4. Bosentan-sildenafil combination in the treatment of patients with severe pulmonary hypertension, and its effect on cardiac function;TROP J PHARM RES;2021

5. Genetic deletion of CMG2 exacerbates systemic‐to‐pulmonary shunt‐induced pulmonary arterial hypertension;The FASEB Journal;2021-03-22